[1]
|
Itoh, N. and Ornitz, D.M. (2011) Fibroblast Growth Factors: From Molecular Evolution to Roles in Development, Metabolism and Disease. Journal of Biochemistry, 149, 121-130. https://doi.org/10.1093/jb/mvq121
|
[2]
|
Tiong, K.H., Mah, L.Y. and Leong, C.O. (2013) Functional Roles of Fibroblast Growth Factor Receptors (FGFRs) Signaling in Human Cancers. Apoptosis, 18, 1447-1468. https://doi.org/10.1007/s10495-013-0886-7
|
[3]
|
Izaguirre, M., et al. (2017) The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes. Current Diabetes Reports, 17, 43. https://doi.org/10.1007/s11892-017-0866-3
|
[4]
|
Li, X. (2019) The FGF Metabolic Axis. Frontiers in Medicine, 13, 511-530.
https://doi.org/10.1007/s11684-019-0711-y
|
[5]
|
Krinsky-McHale, S.J. and Silverman, W. (2013) Dementia and Mild Cognitive Impairment in Adults with Intellectual Disability: Issues of Diagnosis. Developmental Disabilities Research Reviews, 18, 31-42.
https://doi.org/10.1002/ddrr.1126
|
[6]
|
Kunert, S.K., et al. (2017) Klotho and Fibroblast Growth Factor 23 in Cerebrospinal Fluid in Children. Journal of Bone and Mineral Metabolism, 35, 215-226. https://doi.org/10.1007/s00774-016-0746-y
|
[7]
|
Yamashita, T., Yoshioka, M. and Itoh, N. (2000) Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in the Ventrolateral Thalamic Nucleus of the Brain. Biochemical and Biophysical Research Communications, 277, 494-498. https://doi.org/10.1006/bbrc.2000.3696
|
[8]
|
Yamazaki, Y., et al. (2008) Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23. Journal of Bone and Mineral Research, 23, 1509-1518. https://doi.org/10.1359/jbmr.080417
|
[9]
|
Fernandes-Freitas, I. and Owen, B.M. (2015) Metabolic Roles of Endocrine Fibroblast Growth Factors. Current Opinion in Pharmacology, 25, 30-35. https://doi.org/10.1016/j.coph.2015.09.014
|
[10]
|
Yamada, S. and Giachelli, C.M. (2017) Vascular Calcification in CKD-MBD: Roles for Phosphate, FGF23, and Klotho. Bone, 100, 87-93. https://doi.org/10.1016/j.bone.2016.11.012
|
[11]
|
Takashi, Y. and Fukumoto, S. (2018) FGF23 beyond Phosphotropic Hormone. Trends in Endocrinology & Metabolism, 29, 755-767. https://doi.org/10.1016/j.tem.2018.08.006
|
[12]
|
Martin, A., David, V. and Quarles, L.D. (2012) Regulation and Function of the FGF23/Klotho Endocrine Pathways. Physiological Reviews, 92, 131-155. https://doi.org/10.1152/physrev.00002.2011
|
[13]
|
Olauson, H., et al. (2013) Parathyroid-Specific Deletion of Klotho Unravels a Novel Calcineurin-Dependent FGF23 Signaling Pathway That Regulates PTH Secretion. PLOS Genetics, 9, e1003975.
https://doi.org/10.1371/journal.pgen.1003975
|
[14]
|
Bergwitz, C. and Jüppner, H. (2010) Regulation of Phosphate Homeostasis by PTH, Vitamin D, and FGF23. Annual Review of Medicine, 61, 91-104. https://doi.org/10.1146/annurev.med.051308.111339
|
[15]
|
Kuro, O.M. (2019) The Klotho Proteins in Health and Disease. Nature Reviews Nephrology, 15, 27-44.
https://doi.org/10.1038/s41581-018-0078-3
|
[16]
|
Hanks, L.J., et al. (2015) Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults. PLoS ONE, 10, e0122885. https://doi.org/10.1371/journal.pone.0122885
|
[17]
|
Bär, L., et al. (2018) Insulin Suppresses the Production of Fibroblast Growth Factor 23 (FGF23). Proceedings of the National Academy of Sciences of the United States of America, 115, 5804-5809.
https://doi.org/10.1073/pnas.1800160115
|
[18]
|
Vadakke Madathil, S., et al. (2014) Klotho Deficiency Disrupts Hematopoietic Stem Cell Development and Erythropoiesis. The American Journal of Pathology, 184, 827-841. https://doi.org/10.1016/j.ajpath.2013.11.016
|
[19]
|
Babitt, J.L. and Lin, H.Y. (2012) Mechanisms of Anemia in CKD. Journal of the American Society of Nephrology, 23, 1631-1634. https://doi.org/10.1681/ASN.2011111078
|
[20]
|
Ho, B.B. and Bergwitz, C. (2021) FGF23 Signalling and Physiology. Journal of Molecular Endocrinology, 66, R23-r32. https://doi.org/10.1530/JME-20-0178
|
[21]
|
Tholen, S., et al. (2014) Variability of Cognitive Performance during Hemodialysis: Standardization of Cognitive Assessment. Dementia and Geriatric Cognitive Disorders, 38, 31-38. https://doi.org/10.1159/000357803
|
[22]
|
Drew, D.A., et al. (2014) FGF-23 and Cognitive Performance in Hemodialysis Patients. Hemodialysis International, 18, 78-86. https://doi.org/10.1111/hdi.12100
|
[23]
|
Kalaitzidis, R.G., et al. (2013) Risk Factors for Cognitive Dysfunction in CKD and Hypertensive Subjects. International Urology and Nephrology, 45, 1637-1646. https://doi.org/10.1007/s11255-013-0450-y
|
[24]
|
Zhu, B., et al. (2018) Differential Expression of Serum Biomarkers in Hemodialysis Patients with Mild Cognitive Decline: A Prospective Single-Center Cohort Study. Scientific Reports, 8, Article No. 12250.
https://doi.org/10.1038/s41598-018-29760-5
|
[25]
|
Coelho, V.A., et al. (2020) Design and Methodology of the Aging Nephropathy Study (AGNES): A Prospective Cohort Study of Elderly Patients with Chronic Kidney Disease. BMC Nephrology, 21, Article No. 461.
https://doi.org/10.1186/s12882-020-02116-w
|
[26]
|
胡灿芳, 等. 血清成纤维细胞生长因子23klotho蛋白对缺血性卒中后认知障碍发生的预测价值[J]. 山西医药杂志, 2021, 50(16): 2436-2438.
|
[27]
|
刘平国, 战涛, 赵中. 脑小血管病患者血清Klotho、FGF23表达水平变化与疾病进展及认知功能障碍的相关性分析[J]. 卒中与神经疾病, 2021, 28(5): 539-542+555.
|
[28]
|
McGrath, E.R., et al. (2019) Circulating Fibroblast Growth Factor 23 Levels and Incident Dementia: The Framingham Heart Study. PLoS ONE, 14, e0213321. https://doi.org/10.1371/journal.pone.0213321
|
[29]
|
Hensel, N., et al. (2016) Fibroblast Growth Factor 23 Signaling in Hippocampal Cells: Impact on Neuronal Morphology and Synaptic Density. Journal of Neurochemistry, 137, 756-769. https://doi.org/10.1111/jnc.13585
|
[30]
|
Laszczyk, A.M., et al. (2017) Klotho Regulates Postnatal Neurogenesis and Protects against Age-Related Spatial Memory Loss. Neurobiology of Aging, 59, 41-54. https://doi.org/10.1016/j.neurobiolaging.2017.07.008
|
[31]
|
Laszczyk, A.M., et al. (2019) FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function. eNeuro, 6.
https://doi.org/10.1523/ENEURO.0469-18.2019
|
[32]
|
Liu, P., et al. (2011) Impairment of Spatial Learning and Memory in Transgenic Mice Overexpressing Human Fibroblast Growth Factor-23. Brain Research, 1412, 9-17. https://doi.org/10.1016/j.brainres.2011.07.028
|
[33]
|
Toffanello, E.D., et al. (2014) Vitamin D Deficiency Predicts Cognitive Decline in Older Men and Women: The Pro.V.A. Study. Neurology, 83, 2292-2298. https://doi.org/10.1212/WNL.0000000000001080
|
[34]
|
Cararo-Lopes, M.M., et al. (2017) The Relevance of α-Klotho to the Central Nervous System: Some Key Questions. Ageing Research Reviews, 36, 137-148. https://doi.org/10.1016/j.arr.2017.03.003
|
[35]
|
Zeldich, E., et al. (2014) The Neuroprotective Effect of Klotho Is Mediated via Regulation of Members of the Redox System. Journal of Biological Chemistry, 289, 24700-24715. https://doi.org/10.1074/jbc.M114.567321
|
[36]
|
Dubal, D.B., et al. (2014) Life Extension Factor Klotho Enhances Cognition. Cell Reports, 7, 1065-1076.
https://doi.org/10.1016/j.celrep.2014.03.076
|
[37]
|
Shardell, M., et al. (2016) Plasma Klotho and Cognitive Decline in Older Adults: Findings from the InCHIANTI Study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 71, 677-682.
https://doi.org/10.1093/gerona/glv140
|
[38]
|
Degirolamo, C., Sabbà, C. and Moschetta, A. (2016) Therapeutic Potential of the Endocrine Fibroblast Growth Factors FGF19, FGF21 and FGF23. Nature Reviews Drug Discovery, 15, 51-69. https://doi.org/10.1038/nrd.2015.9
|